These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31938433)

  • 21. [The Expression of Pokemon in Endometrial Carcinoma Tissue and the Correlation with Mutant p53].
    Yi TJ; Wang P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 May; 47(3):321-5. PubMed ID: 27468473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of hPEBP4 negatively correlates with estrogen and progesterone receptors in endometrial carcinoma.
    Guo T; Li B; Gu C
    J BUON; 2013; 18(2):465-70. PubMed ID: 23818363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biochemical analysis of estrogen receptor and progesterone receptor in normal uterus and endometrial carcinoma].
    Saito N
    Nihon Naibunpi Gakkai Zasshi; 1987 Feb; 63(2):87-101. PubMed ID: 3569607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance on expressions of Annexin-I and its correlative gene proteins in endometrial hyperplasia, atypical hyperplasia and endometrial carcinoma].
    Da J; Meng X; Wang P; Yang Z; Zhu Y
    Zhonghua Bing Li Xue Za Zhi; 2001 Aug; 30(4):256-9. PubMed ID: 11758212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C; Wejaranayang C; Vipupinyo C
    J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
    Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of body mass index with ER, PR and 14-3-3σ expression in tumor and stroma of type I and type II endometrial carcinoma.
    Peevey JF; Seagle BL; Maniar KP; Kim JJ
    Oncotarget; 2017 Jun; 8(26):42548-42559. PubMed ID: 28476021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A; Milkov V
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
    Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
    World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification.
    Karnezis AN; Leung S; Magrill J; McConechy MK; Yang W; Chow C; Kobel M; Lee CH; Huntsman DG; Talhouk A; Kommoss F; Gilks CB; McAlpine JN
    J Pathol Clin Res; 2017 Oct; 3(4):279-293. PubMed ID: 29085668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR).
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Kriegel S; Kupka MS; Friese K
    Anticancer Res; 2005; 25(3A):1679-86. PubMed ID: 16033082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Human telomerase P53 estrogen and progesterone receptor expression in endometrial carcinoma].
    Dong Y; Li T; Liang Y; Zou WZ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 36(1):61-5. PubMed ID: 14970891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
    Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
    J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathologic features and sex steroid receptor status.
    Koshiyama M; Yoshida M; Konishi M; Takemura M; Yura Y; Matsushita K; Hayashi M; Tauchi K
    Int J Cancer; 1997 Jun; 74(3):237-44. PubMed ID: 9221798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Estrogen and progesterone receptors as prognostic markers in endometrial carcinoma].
    Gorchev G; Milkov V
    Akush Ginekol (Sofiia); 1992; 31(2):32-3. PubMed ID: 1342555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Researches on the Correlation Between Estrogen and Progesterone Receptors Expression and Disease-Free Survival of Endometrial Cancer.
    Ren S; Wu J; Yin W; Liao Q; Gong S; Xuan B; Mu X
    Cancer Manag Res; 2020; 12():12635-12647. PubMed ID: 33335423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
    Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
    J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of T cell receptor gamma alternate reading frame protein and keratin 5 in endometrial carcinoma.
    Zhao LJ; Li XP; Qi WJ; Wang JL; Wei LH
    Chin Med J (Engl); 2013 Nov; 126(22):4260-4. PubMed ID: 24238509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Estrogen and progesterone receptors in endometrial carcinoma].
    Guo Y; Dang Q
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):418-21. PubMed ID: 9639729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer.
    Wang C; Tran DA; Fu MZ; Chen W; Fu SW; Li X
    J Cancer; 2020; 11(7):1693-1701. PubMed ID: 32194781
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.